These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 34018468)

  • 1. Molecular dynamics simulation of bioactive compounds of
    Begum S; Shadrack DM; Joseph FM; Ndensendo VMK
    J Biomol Struct Dyn; 2022; 40(19):9279-9286. PubMed ID: 34018468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.
    Jadaun P; Harshithkumar R; Gaikwad SY; Seniya C; Borse S; Gawai AA; Chavan-Gautam P; Tillu G; Mukherjee A
    Virol J; 2023 Aug; 20(1):173. PubMed ID: 37537596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withanolides production by the endophytic fungus Penicillium oxalicum associated with Withania somnifera (L.) Dunal.
    Gupta A; Vasundhara M
    World J Microbiol Biotechnol; 2024 May; 40(7):215. PubMed ID: 38802663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
    Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
    J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withania frutescens (L.) Pauquy, a valuable Mediterranean shrub containing bioactive withanolides.
    Bouissane L; Bailly C
    Steroids; 2024 Jul; 207():109439. PubMed ID: 38740121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New withanolides from leaves along with alkyl glucoside from roots and stem as well as variations in withanolide contents in leaves of accessions of
    Lal P; Misra L; Sangwan NS; Sangwan RS
    J Asian Nat Prod Res; 2024 Sep; 26(9):1009-1023. PubMed ID: 38311941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor withanolides as signal transducers and activators of transcription 3 (STAT3)-inhibition from Withania obtusifolia.
    Zou Q; Chunduru J; LaRoe N; Yang Y; Mohamed TA; Hegazi NM; Ibrahim MAA; Hegazy MF; Pappas D; Paré PW
    Fitoterapia; 2024 Sep; 177():106124. PubMed ID: 38996879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of three CYP450 genes reveals their role in withanolides formation and defense in Withania somnifera, the Indian Ginseng.
    Shilpashree HB; Sudharshan SJ; Shasany AK; Nagegowda DA
    Sci Rep; 2022 Jan; 12(1):1602. PubMed ID: 35102209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of apigenin-4'-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies.
    Harini M; Kavitha K; Prabakaran V; Krithika A; Dinesh S; Rajalakshmi A; Suresh G; Puvanakrishnan R; Ramesh B
    J Mol Model; 2024 Jan; 30(1):22. PubMed ID: 38170229
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Roney M; Issahaku AR; Forid MS; Huq AKMM; Soliman MES; Mohd Aluwi MFF; Tajuddin SN
    J Biomol Struct Dyn; 2023; 41(24):14904-14913. PubMed ID: 36995164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive metabolites from the leaves of Withania adpressa.
    Ben Bakrim W; El Bouzidi L; Nuzillard JM; Cretton S; Saraux N; Monteillier A; Christen P; Cuendet M; Bekkouche K
    Pharm Biol; 2018 Dec; 56(1):505-510. PubMed ID: 30451050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.
    Cavaleri F; Chattopadhyay S; Palsule V; Kar PK; Chatterjee R
    Integr Cancer Ther; 2024; 23():15347354231223499. PubMed ID: 38281118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor repertoire in Ashwagandha (Withania somnifera) through analytics of transcriptomic resources: Insights into regulation of development and withanolide metabolism.
    Tripathi S; Sangwan RS; Narnoliya LK; Srivastava Y; Mishra B; Sangwan NS
    Sci Rep; 2017 Nov; 7(1):16649. PubMed ID: 29192149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential inhibitors of FemC to combat
    Rathi R
    J Biomol Struct Dyn; 2023 Dec; 41(20):10495-10506. PubMed ID: 36524526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the potential and identifying
    Gurushankar K; Rimac H; Nadezhda P; Grishina M
    J Biomol Struct Dyn; 2023; 41(23):13963-13976. PubMed ID: 36762693
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lingfa L; Tirumala A; Ankanagari S
    Evid Based Complement Alternat Med; 2023; 2023():8832166. PubMed ID: 38169931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Insight into the Mechanism of Action of DNA Gyrase Inhibitors; Revealing a New Mechanism.
    Muhammed MT; Aki-Yalcin E
    Curr Comput Aided Drug Des; 2024; 20(3):224-235. PubMed ID: 37114781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of starvation-mimetic bioactive phytocomponent from
    Pradhan D; Biswasroy P; Kulkarni S; Taliyan R; Pradhan DK; Bhola RK; Mahapatra S; Ghosh G; Rath G
    J Biomol Struct Dyn; 2024; 42(1):528-549. PubMed ID: 37087726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis.
    Santhi N; Aishwarya S
    Bioinformation; 2011; 7(1):1-4. PubMed ID: 21904430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and unveiling antibacterial mechanism of dandelion phenolic extracts against
    Xu X; Wang X; Xie P
    J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38174403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.